12:00 AM
 | 
Mar 04, 2013
 |  BioCentury  |  Finance

Gimv's risk reduction

Gimv diversifying risk with new fund for healthcare services, medtech
Gimv's risk reduction

Gimvmaintains that biotech companies need not worry that the firm's new Health & Care Fund includes only two of the VC's three pillar investment areas in that sector - medtech and healthcare services - but not life sciences.

According to spokesperson Frank De Leenheer, Gimv makes almost all of its biotech investments from its Euronext-listed vehicle...

Read the full 270 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >